SMARCB1 mutations are already present in the germline in up to 30% of patients, who then suffer from a rhabdoid tumor predisposition syndrome 1 (RTPS1; OMIM #609322) [10, 25]. The gene discussed is SMARCB1; the disease is rhabdoid tumor.